Vaccination with B7-1+ tumor and anti-adhesion therapy with RGD pseudo- peptide (FC-336) efficiently induce anti-metastatic effect

Clinical and Experimental Metastasis

Volumn 16, Issue 2, 1998, Pages 141-148

  Fujii, Hideki ^a,b   Inobe, Manabu ^b   Hayakawa, Yoshihiro ^a   Kimura, Fuminari ^a   Murakami, Masaaki ^b   Onishi, Yasuharu ^a   Azuma, Ichiro ^b   Uede, Toshimitsu ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adhesion; B7; Metastasis; Pseudo peptide; Vaccination

Indexed keywords

B7 ANTIGEN; CANCER VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; FEMALE; GENETIC TRANSFECTION; HOST RESISTANCE; LUNG METASTASIS; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN;

EID: 0031798526     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021985002088     Document Type: Article

References (25)

1. Liotta LA, Rao CV and Barsky SH, 1983, Tumor invasion and the extracellular matrix. Lab Invest, 49, 636-49.
2. Fidler IJ, 1984, The Ernst, W. Bertner Memorial Award Lecture: The evolution of biological heterogeneity in metastatic neoplasmas. In: Nicolson GL and Milas L, eds. Cancer Invasion and Metastasis: biologic and therapeutic aspects. New York: Raven Press, pp. 5-26.
3. Nicolson GL, 1987, Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncofetal expression. Cancer Res, 47, 1473-87.
4. Terranova VP, Liotta LA, Russo RG and Martin GR, 1982, Role of laminin in the attachment and metastasis of murin tumor cells. Cancer Res, 42, 2265-9.
5. Chen L, Linsley PS and Hellström KE, 1993, Costimulation of T cells for tumor immunity. Immunol Today, 14, 483-6.
6. Li Y, Mcgowan P, Hellström I, Hellström KE and Chen L, 1994, Costimulation of tumor-reactive CD4+ and CD8+ T-lymphocytes by B7, a natural ligand for CD28, can be utilized to treat established mouse melanoma. J Immunol, 153, 421-8.
7. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J Exp Med, 181, 619-29.
8. Chen L, Ashe S, Brady WA, Hellström I, Ledbetter JA, Mcgowan P and Linsley PS, 1992, Costimulation of antitumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-102.
9. + T cells by B7-1 transfected melanoma cells. Science, 259, 368-70.
10. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ and Glimcher LH, 1993, Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA, 90, 5687-90 .
11. Chen L, Mcgowan P, Ashe S, et al. 1994, Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med, 179, 523-32.
12. Fujii H, Inobe M, Kimura F, et al. 1996, Vaccination of tumor cells transfected with the B7-1(CD80) gene induces the anti-metastatic effect and tumor immunity in mice. Int J Cancer, 66, 219-24.
13. Humphries MJ, Olden K and Yamada KM, 1986, A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467-70.
14. Humphries MJ, Yamada KM and Olden K, 1986, Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. J Clin Invest, 81, 782-90.
15. Iwamoto Y, Robey FA, Graf J, Sasaki M, et al. 1987, YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science, 237, 1132-4.
16. Azuma I and Saiki I, 1994, Prevention of cancer metastasis in mice with fibronectin-related substances. In: Hirohashi S, Moses HL, Ruoslahti E, Sugimura T, Takeichi M and Terada M, eds. Proceeding of the International Symposium of the Princess Takamatsu Cancer Research Fund: molecular and cellular basis for cell to cell interaction: its significance in cancer. Princeton, NJ: Princeton Scientific Publishing Co., Inc., pp. 125-41.
17. Saiki I, Murata J, Sakurai T, et al. 1989, Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences. Br J Cancer, 60, 722-8.
18. Saiki I, Iida J, Murata J, et al. 1989, Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequence of cell adhesive molecules. Cancer Res, 49, 3815-22.
19. Saiki I, Murata J, Nishi N, Sugimura K and Azuma I, 1989, The inhibition of murine lung metastasis by synthetic polypeptides [poly(Arg-Gly-Asp) and poly(Tyr-Ile-Gly-Ser-Arg)] with a core sequence of cell adhesion molecules. Br J Cancer, 59, 194-7.
20. Saiki I, Murata J, Makabe T, et al. 1990, Inhibition of tumor angiogenesis by a synthetic cell-adhesive polypeptide containing the Arg-Gly-Asp (RGD) sequence of fibronectin, poly (RGD). Jpn J Cancer Res, 81, 668-75.
21. Ugen KE, Mahalingan M, Klein PA and Kao KJ, 1988, Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by synthetic Gly-Arg-Gly-Asp-Ser peptide. J Natl Cancer Inst, 80, 1461-6.
22. Kumagai H, Tajima M, Ueno Y, Hama YG and Ohba M, 1991, Effect of cyclic RGD peptide on cell adhesion and tumor metastasis. Biochem Biophys Res Commun, 177, 74-82.
23. Fujii H, Nishikawa N, Komazawa H, et al. 1996, Inhibition of tumor invasion and metastasis by peptide mimetics of Arg-Gly-Asp(RGD) derived from the cell recognition site of fibronectin. Oncol Res, 8, 333-42.
24. Fujii H, Nishikawa N, Komazawa H, et al. 1997, A new pseudo-peptide of Arg-Gly-Asp(RGD) with inhibitory effect on tumor metastasis and enzymatic degradation of extracellular matrix. Clin Expl Metastasis, in press.
25. Hart IR, 1979, The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol, 97, 587-92.